Science Explorer Interactive view Map
Company · Derio · Spain

Oncomatryx (Spain)

oncomatryx.comROR OpenAlex
Research works
4
▲ 36% vs 2013–17
Citations
36
8.8 per fractional work
Top-10% rate
12.7%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: Oncomatryx (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Oncomatryx (Spain) publish most on?

By volume in 2022–2025: Inflammatory mediators and NSAID effects, Nanoplatforms for cancer theranostics, Estrogen and related hormone effects and Ubiquitin and proteasome pathways.

Inflammatory mediators a…0Inflammatory mediators and NSAID effects: 0 fractional worksNanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional worksEstrogen and related hormone effects: 0 fractional worksUbiquitin and proteasome…0Ubiquitin and proteasome pathways: 0 fractional worksNitric Oxide and Endothe…0Nitric Oxide and Endothelin Effects: 0 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksCancer Cells and Metasta…0Cancer Cells and Metastasis: 0 fractional worksMicroRNA in disease regulation: 0 fractional worksExtracellular vesicles in disease: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional works
PharmacologyBiomedical EngineeringGeneticsMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Inflammatory mediators and NSAID effects Pharmacology 0 works
  2. 2 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  3. 3 Estrogen and related hormone effects Genetics 0 works
  4. 4 Ubiquitin and proteasome pathways Molecular Biology 0 works
  5. 5 Nitric Oxide and Endothelin Effects Physiology 0 works
  6. 6 Peptidase Inhibition and Analysis Oncology 0 works
  7. 7 Cancer Cells and Metastasis Oncology 0 works
  8. 8 MicroRNA in disease regulation Cancer Research 0 works
  9. 9 Extracellular vesicles in disease Molecular Biology 0 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.6%not open52.4%

World: 28% of research is openly available.

with international co-authors46.7%domestic only53.3%

World: 19% is written across borders.

How has Oncomatryx (Spain)'s research output changed?

Output in 2018–2022 was 36% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Derio

All research institutions in Derio

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.